Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Earnings Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
AMAZON.COM, INC.
TESLA, INC.
APPLE INC.
NVIDIA CORPORATION
META PLATFORMS, INC.
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
All our stock picks
North America
Europe
Asia, Pacific
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Dividend Aristocrats
Trend-Following Stocks
Small caps
Multibaggers
Yield stocks
Top ROE
Investment Themes
Homepage
The Vegan Market
Cloud Computing
Semiconductors
The food of tomorrow
Boats
Ageing Population
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
Place your bets
Space Exploration
Defense
Education
The Golden Age of Video Games
Robotics
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Earnings Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
Switzerland
Swiss Exchange
IGEA Pharma N.V.
News
All News
IGPH
NL0012768675
IGEA PHARMA N.V.
(IGPH)
Add to my list
Report
Delayed Swiss Exchange -
11:35:27 2023-06-08 am EDT
0.006000
CHF
+20.00%
06/01
Achiko, IGEA, Talenthouse Shares Suspended from Trading on SIX Swiss Exchange
MT
06/01
IGEA Pharma Seeks Deadline Extension for FY22 Annual Report Publication
MT
05/31
Igea Pharma N.v. : IGEA to apply for a further extension of its disclosure obligations
EQ
Summary
Quotes
Charts
News
Calendar
Company
Financials
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
All news about IGEA PHARMA N.V.
06/01
Achiko, IGEA, Talenthouse Shares Suspended from Trading on SIX Swiss Exchange
MT
06/01
IGEA Pharma Seeks Deadline Extension for FY22 Annual Report Publication
MT
05/31
Igea Pharma N.v. : IGEA to apply for a further extension of its disclosure obligations
EQ
05/31
Igea Pharma N : to apply for a further extension of its disclosure obligations
PU
05/30
IGEA Pharma to Divest Industrial Process Business in Refocusing Move
MT
05/29
Igea Pharma N.v. : IGEA to update on strategic refocusing decisions.
EQ
05/15
Igea Pharma N : to update on unaudited key figures and ongoing matters
PU
05/15
Igea Pharma N.v. : IGEA to update on unaudited key figures and ongoing matters
EQ
05/01
Igea Pharma N.v. : IGEA to get SIX approval to Annual Report 2022 disclosure
EQ
05/01
Igea Pharma N : Minutes of the EGM of 24 April 2023 + Attendance list
PU
05/01
Igea Pharma N : to get SIX approval to Annual 2022 Report disclosure
PU
04/13
IGEA Pharma Receives Fine for Breach of Listing Rules
MT
03/13
Igea Pharma N : Convening notice & Agenda
PU
2022
Igea Pharma N : appoints new Chief Financial Officer
PU
2022
Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022
Igea Pharma N : announces annual General Meeting Resolutions
PU
2022
IGEA Pharma's H1 Loss Shrinks Amid Lower Expenses
MT
2022
Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
2022
IGEA Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022
Igea Pharma N.v. : Igea discloses its 2021 annual report
EQ
2022
Igea Pharma N : Convening Notice and Agenda
PU
2022
IGEA Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2022
Igea Pharma N.v. : IGEA to get SIX approval to the semi-annual 2022 report disclosure
EQ
2022
Igea Pharma N : to get SIX approval to the semi-annual 2022 report disclosure
PU
2022
Swiss Exchange Regulator Investigates IGEA Pharma For Violating Reporting Rules
MT
2022
Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022
Igea Pharma N : to get SIX further approval to the 2021 annual report disclosure
PU
2022
IGEA Pharma Suspends Trading Amid Delayed FY21 Annual Report
MT
2022
Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022
IGEA Pharma Close to Finalizing $6 Million Investment Deal For Cannabidiol Extraction F..
MT
2022
Igea Pharma N.v. : Igea pharma has announced that lmh - an industrial holding company - ha..
EQ
2022
Igea Pharma N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
2022
Igea Pharma N : Note of the Board
PU
2022
Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022
Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
2022
Igea Pharma N.v. : Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
2022
IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication
MT
2022
Igea Pharma N.v. : IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
2022
Igea Pharma N : to get SIX approval to delay the 2021 annual report disclosure
PU
2022
Igea Pharma N : non-executive board members resigned after completion of the first post-co..
PU
2021
Igea Pharma N : GBC Research report IGEA Pharma N.V.
PU
2021
Igea Pharma N : GBC AG Publishes initial equity research report with buy recommendation an..
PU
2021
Igea Pharma N.v. : Gbc ag publishes initial equity research report with buy recommendation..
EQ
2021
Igea Pharma N : GBC AG to start equity coverage of IGEA Pharma
PU
2021
IGEA Pharma N : H1 Loss Narrows on Gains From Financial Liabilities, Sale ..
MT
2021
IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
2021
Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021
Igea Pharma N : discloses its half-2021 financials
PU
2021
Igea Pharma N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
2021
Igea Pharma N : to submit the listing prospectus to the SIX following the business combina..
PU
2021
Igea Pharma N : to boost revenues entering the growing cannabis market
PU
2021
IGEA Pharma N : Expects Earnings, Revenue Boost On Blue Sky Natural Resour..
MT
2021
IGEA Pharma N : Declares All-Equity Offer for Blue Sky Natural Resources U..
MT
2021
Igea Pharma N : Minutes of the AGM 9 July 2021 + Attendance list
PU
2021
Igea Pharma N : announces Annual General Meeting resolutions
PU
2021
IGEA Pharma N : Launches All-Equity Offer To Buy Blue Sky Natural Resource..
MT
2021
Igea Pharma N : To launch the all equity offer to blue sky natural resources ltd.
EQ
2021
Igea Pharma N : Convening notice and agenda
PU
2021
IGEA Pharma N : Names New Chair
MT
2021
Igea Pharma N : announces changes in its board and other corporate updates
EQ
2021
IGEA Pharma N.V. Announces Executive Changes
CI
2021
Igea Pharma N : announces changes in its board and other corporate updates
PU
2021
Igea Pharma N : disclosed its Annual Report 2020
EQ
2021
Igea Pharma : Annual report
PU
2021
Igea Pharma N : disclosed its Annual Report 2020
PU
2021
IGEA Pharma N : Secures $12 Million Investment From Negma
MT
2021
IGEA Pharma N.V. Reports Unaudited Earnings Results for the Year 2020
CI
2021
Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
EQ
2021
Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
PU
2021
Igea Pharma N : announces extraordinary general meeting results
EQ
2021
Igea Pharma N : announces extraordinary general meeting results
PU
2021
Igea Pharma N : Minutes of the EGM 28 April 2021
PU
2021
IGEA Pharma Strikes Two-Year Convertible Bond Deal With Negma
MT
2021
Igea Pharma N : to secure convertible bond commitment with Negma Group
PU
2021
Igea Pharma N : to secure convertible bond commitment with Negma Group
EQ
1
2
Next
Upcoming event on IGEA PHARMA N.V.
06/30/23
Annual General Meeting
Company calendar
Upcoming sector events
07/26/23
LANTHEUS HOLDINGS : Q2 2023 Earnings Release (Projected)
07/27/23
DIASORIN S.P.A. : Q2 2023 Earnings Release
08/02/23
10X GENOMICS : Q2 2023 Earnings Release (Projected)
08/28/23
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. : Q2 2023 Earnings Release (Projected)
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
Slave